×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
CVE:SLS

Solaris Resources (SLS) Stock Forecast, Price & News

C$6.15
-0.17 (-2.69%)
(As of 02/8/2021)
Add
Compare
Today's Range
C$5.95
C$6.35
50-Day Range
N/A
52-Week Range
C$1.38
C$7.09
Volume
53,313 shs
Average Volume
132,199 shs
Market Capitalization
C$643.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SLS News and Ratings via Email

Sign-up to receive the latest news and ratings for Solaris Resources and its competitors with MarketBeat's FREE daily newsletter.

Solaris Resources logo

About Solaris Resources

SELLAS is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapeutics for a broad range of cancer indications. SELLAS' lead product candidate, GPS, is licensed from Memorial Sloan Kettering Cancer Center and targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination to address a broad spectrum of hematologic malignancies and solid tumor indications. SELLAS' second product candidate, NPS, is a HER2-directed cancer immunotherapy with potential for the treatment of patients with early-stage breast cancer with low to intermediate HER2 expression, otherwise known as HER2 1+ or 2+, which includes triple negative breast cancer patients, following standard of care.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry
Pharmaceutical Preparation Manufacturing
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
C$643.73 million
Optionable
Optionable

Company Calendar

Today
5/28/2022
Next Earnings (Estimated)
8/12/2022

MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Solaris Resources (CVE:SLS) Frequently Asked Questions

When is Solaris Resources' next earnings date?

Solaris Resources is scheduled to release its next quarterly earnings announcement on Friday, August 12th 2022.
View our earnings forecast for Solaris Resources
.

What is Solaris Resources' stock symbol?

Solaris Resources trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SLS."

How do I buy shares of Solaris Resources?

Shares of SLS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Solaris Resources' stock price today?

One share of SLS stock can currently be purchased for approximately C$6.15.

How much money does Solaris Resources make?

Solaris Resources has a market capitalization of C$643.73 million.

How many employees does Solaris Resources have?

Solaris Resources employs 7 workers across the globe.

What is Solaris Resources' official website?

The official website for Solaris Resources is www.sellaslifesciences.com.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.